Drug Type Biological products |
Synonyms SMC-108 |
Target |
Action modulators |
Mechanism bFGF modulators(Fibroblast growth factor 2 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Bone injury | Discovery | United States | - | |
| Cartilage Diseases | Discovery | United States | - | |
| Gastrointestinal Diseases | Discovery | United States | - | |
| Heart Diseases | Discovery | United States | - | |
| Multiple Sclerosis | Discovery | United States | - | |
| Osteoarthritis | Discovery | United States | - | |
| Scleroderma, Systemic | Discovery | United States | - | |
| Wounds and Injuries | Discovery | United States | - |





